JPS58174317A - ジベンゾシクロヘプタジエンとコデルゴクリンを含有する薬学的組成物 - Google Patents

ジベンゾシクロヘプタジエンとコデルゴクリンを含有する薬学的組成物

Info

Publication number
JPS58174317A
JPS58174317A JP58044528A JP4452883A JPS58174317A JP S58174317 A JPS58174317 A JP S58174317A JP 58044528 A JP58044528 A JP 58044528A JP 4452883 A JP4452883 A JP 4452883A JP S58174317 A JPS58174317 A JP S58174317A
Authority
JP
Japan
Prior art keywords
active agent
depression
preparation according
activator
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP58044528A
Other languages
English (en)
Japanese (ja)
Inventor
ロバ−ト・ダブリユ−・グリフイス
ジヤツク・シンガ−
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sandoz AG
Original Assignee
Sandoz AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz AG filed Critical Sandoz AG
Publication of JPS58174317A publication Critical patent/JPS58174317A/ja
Pending legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/26Psychostimulants, e.g. nicotine, cocaine

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP58044528A 1982-03-22 1983-03-18 ジベンゾシクロヘプタジエンとコデルゴクリンを含有する薬学的組成物 Pending JPS58174317A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US36046382A 1982-03-22 1982-03-22
US360463 1994-12-21

Publications (1)

Publication Number Publication Date
JPS58174317A true JPS58174317A (ja) 1983-10-13

Family

ID=23418055

Family Applications (1)

Application Number Title Priority Date Filing Date
JP58044528A Pending JPS58174317A (ja) 1982-03-22 1983-03-18 ジベンゾシクロヘプタジエンとコデルゴクリンを含有する薬学的組成物

Country Status (18)

Country Link
JP (1) JPS58174317A (sv)
AU (1) AU1262283A (sv)
BE (1) BE896170A (sv)
CA (1) CA1197465A (sv)
CH (1) CH652927A5 (sv)
DE (1) DE3308855A1 (sv)
FR (1) FR2527077B1 (sv)
GB (1) GB2116843B (sv)
GR (1) GR77165B (sv)
HU (1) HU190714B (sv)
IL (1) IL68184A (sv)
IT (1) IT1163156B (sv)
NL (1) NL8300986A (sv)
NZ (1) NZ203632A (sv)
PH (1) PH22086A (sv)
PT (1) PT76417B (sv)
SE (1) SE8301530L (sv)
ZA (1) ZA832005B (sv)

Also Published As

Publication number Publication date
CH652927A5 (de) 1985-12-13
IL68184A0 (en) 1983-06-15
FR2527077B1 (fr) 1986-08-22
NL8300986A (nl) 1983-10-17
HU190714B (en) 1986-10-28
SE8301530D0 (sv) 1983-03-21
FR2527077A1 (fr) 1983-11-25
PH22086A (en) 1988-05-20
IL68184A (en) 1986-04-29
AU1262283A (en) 1983-09-29
ZA832005B (en) 1984-11-28
GB8307751D0 (en) 1983-04-27
GR77165B (sv) 1984-09-10
IT8320186A0 (it) 1983-03-21
CA1197465A (en) 1985-12-03
PT76417A (en) 1983-04-01
IT1163156B (it) 1987-04-08
NZ203632A (en) 1986-09-10
PT76417B (en) 1985-12-16
GB2116843A (en) 1983-10-05
SE8301530L (sv) 1983-09-23
DE3308855A1 (de) 1983-09-29
BE896170A (fr) 1983-09-16
GB2116843B (en) 1986-01-15

Similar Documents

Publication Publication Date Title
AU2003227516B2 (en) A combination of an NMDA-antagonist and acetylcholine esterase inhibitors for the treatment of alzheimer's disease
DE3873879T2 (de) Nicht-sedative antihistaminica enthaltende husten-/schnupfenmittel.
JP4925074B2 (ja) ミルタザピンと1種以上の選択的セロトニン再取り込み阻害剤とを含む医薬組成物
US20060030587A1 (en) Method of treating attention deficit disorders with d-threo methylphenidate
US6191153B1 (en) Use of 2-amino-6-n-propyl-amino-4,5,6,7-tetrahydrobenzothiazole as a pharmaceutical composition having an antidepressant activity
JP2904827B2 (ja) 不安および不安抑うつ障害の処置に有用な医薬組成物の調製へのトリフルオロメチルフェニルテトラヒドロピリジンの使用
WO2021262196A1 (en) Compositions and methods for treating alzheimer's disease and parkinson's disease
JPS59193821A (ja) 抗不安薬としてのフルオキセチンの使用法
JPS6357405B2 (sv)
US20090203727A1 (en) Novel pharmaceutical composition and its use in a method for treatment of patients with upper respiratory mucosal congestion
US3954988A (en) Use of lisuride and physiologically acceptable salts thereof to achieve psychic energizer effects
IE904084A1 (en) Treatment of depression
US6372763B1 (en) Treatment and prevention of cardiac disorders using selective serotonin re-uptake inhibitors (SSRI)
EP1615641A1 (en) Combinations of paroxetine and 2-(r)-(4-fluoro-2-methyl-phenyl)-4-(s)-((8as)-6-oxo-hexahydro-pyrrolo 1,2-a -pyrazin-2-yl)-piperidine-1-carboxylic acid 1-(r)-(3,5-bis-trifluoromethyl-phenyl)-ethyl -methylamide for treatment of depression/anxiety
JPS58174317A (ja) ジベンゾシクロヘプタジエンとコデルゴクリンを含有する薬学的組成物
US4593031A (en) Method of treating depression
KR20010105418A (ko) 기분 장애 치료용 오사네턴트
US3505451A (en) Compositions and methods for alleviating schizophrenia employing one of haloperidol,trifluperidol or an acid addition salt thereof and one of desipramine,imipramine and an acid addition salt thereof
EP0567498A1 (en) Pharmaceutical composition containing granisetron and dexamethasone
WO1991012805A1 (en) Method of treating therapy-resistant schizophrenia with amperozide
JPS6144816A (ja) 組み合わせ生成物およびその調製方法
ZA200409147B (en) A combination of an NMDA-antagonist and acetylcholine esterase inhibitors for the treatment of alzheimer's disease
JPS6116A (ja) 有機化合物に関する改良
US3900566A (en) Pharmaceutical compositions containing the tert butyl ester of n-((1-carboxy-l-prolyl)-oxy)-succinimide and method of use
CA2558708A1 (en) A combination of an nmda-antagonist and acetylcholine esterase inhibitors for the treatment of alzheimer's disease